Form4insider filings, from the source

SEC Form 4 · accession 0001562180-19-000874

REGENXBIO Inc. · RGNX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Vittal Vasista
Officer — Chief Financial Officer
Period of report
Feb 7, 2019
Accepted (ET)
Feb 11, 2019 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 7, 2019M120,000$0.85A242,283D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F1,F2$0.85Feb 7, 2019M120,000D—Sep 23, 2024Common Stock120,00084,900D

Explanation of responses